Breaking News Instant updates and real-time market news.

EHTH

eHealth

$62.23

0.32 (0.52%)

16:38
04/25/19
04/25
16:38
04/25/19
16:38

eHealth reports Q1 adj. EPS 33c, may not compare to consensus (10c)

Reports Q1 revenue $68.8M, may not compare to consensus $51.1M.

  • 25

    Apr

  • 28

    May

EHTH eHealth
$62.23

0.32 (0.52%)

04/17/19
RBCM
04/17/19
NO CHANGE
Target $83
RBCM
Outperform
eHealth selloff not related to company specific news, says RBC Capital
RBC Capital analyst Frank Morgan says he's found no company specific news that would explain the weakness today in shares of eHealth. Rather, the analyst attributes the 22% pullback to continued selling in managed care operators and providers, which began yesterday morning. He attributes yesterday's sell-off to Democratic presidential candidate rhetoric around Medicare-for-All, including a tweet from candidate Bernie Sanders during UnitedHealth's Q1 earnings call advocating for MFA. Morgan believes investors were looking to take profits in any strong year-to-date performers, like eHealth. The analyst has an Outperform rating on the stock with an $83 price target. eHealth in afternoon trading is down 22%, or $14.05, to $51.38.
04/17/19
CHLM
04/17/19
NO CHANGE
Target $75
CHLM
Buy
Craig-Hallum sees opportunity to buy eHealth on 'Medicare-for-all silliness'
Noting that eHealth is down more than 20% on what he calls "Medicare-for-all silliness," Craig-Hallum analyst George Sutton said investors are "acting as if it perhaps could be real" and might happen but he believes "Medicare-for-all won't happen. It isn't a reality." However, "if this alternative universe were to exist," it would potentially be positive for eHealth, which could function as a value-add service provider and help people match needs beyond government offered plans with the appropriate level of care, Sutton tells investors. In the current "real world," eHealth is executing very well and the pullback presents an "excellent opportunity to get involved," concludes Sutton, who keeps a Buy rating and $75 price target on the stock.
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
Buy
eHealth pullback presents 'very attractive' entry point, says SunTrust
SunTrust analyst Tobey Sommer said he views the mid-teen percentage decline in eHealth (EHTH) shares amid worries about Medicare for all proposals as presenting a "very attractive" entry point, noting that applying the same multiple paid by Willis Towers Watson (WLTW) for Tranzact implies a $62 share price for eHealth. While eHealth has a lower EBITDA margin, its revenue is growing faster and it has exposure in the individual and small business markets as well as the main Medicare business. The analyst, who believes eHealth's multi-year top-line growth outlook is substantially superior to consensus forecasts, driven by superior Medicare growth, keeps a Buy rating on the shares.
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
eHealth weakness a buying opportunity, says SunTrust

TODAY'S FREE FLY STORIES

CABO

Cable One

$1,111.46

-18.95 (-1.68%)

08:02
06/27/19
06/27
08:02
06/27/19
08:02
Recommendations
Cable One analyst commentary  »

Cable One price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$85.74

0.32 (0.37%)

08:01
06/27/19
06/27
08:01
06/27/19
08:01
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:00
06/27/19
06/27
08:00
06/27/19
08:00
Options
Tesla put buyer realizes 36% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:57
06/27/19
06/27
07:57
06/27/19
07:57
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

BB

BlackBerry

$7.55

-0.74 (-8.93%)

07:56
06/27/19
06/27
07:56
06/27/19
07:56
Recommendations
BlackBerry analyst commentary  »

BlackBerry execution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SM

SM Energy

$12.56

0.63 (5.28%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Initiation
SM Energy initiated  »

SM Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

07:55
06/27/19
06/27
07:55
06/27/19
07:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

ITRI

Itron

$60.88

0.48 (0.79%)

07:55
06/27/19
06/27
07:55
06/27/19
07:55
Conference/Events
Itron to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

XEC

Cimarex Energy

$57.17

1.64 (2.95%)

07:53
06/27/19
06/27
07:53
06/27/19
07:53
Initiation
Cimarex Energy initiated  »

Cimarex Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COUP

Coupa Software

$119.01

-1.3 (-1.08%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Recommendations
Coupa Software analyst commentary  »

Coupa Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

LECO

Lincoln Electric

$79.77

0.1 (0.13%)

07:52
06/27/19
06/27
07:52
06/27/19
07:52
Downgrade
Lincoln Electric rating change  »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$42.13

0.455 (1.09%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Conference/Events
Eaton Vance to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$10.33

-0.13 (-1.24%)

07:50
06/27/19
06/27
07:50
06/27/19
07:50
Upgrade
Luther Burbank rating change at Sandler ONeill »

Luther Burbank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$20.29

0.54 (2.73%)

07:49
06/27/19
06/27
07:49
06/27/19
07:49
Hot Stocks
Qiwi appoints Vladislav Poshmorga as CFO »

QIWI announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:48
06/27/19
06/27
07:48
06/27/19
07:48
Upgrade
KB Home rating change  »

KB Home upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$42.28

-0.92 (-2.13%)

07:47
06/27/19
06/27
07:47
06/27/19
07:47
Recommendations
National Beverage analyst commentary  »

Guggenheim says National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIVE

Aerohive

$4.44

1.26 (39.62%)

07:46
06/27/19
06/27
07:46
06/27/19
07:46
Downgrade
Aerohive rating change at Craig-Hallum »

Aerohive downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMGN

ImmunoGen

$1.95

0.14 (7.73%)

07:45
06/27/19
06/27
07:45
06/27/19
07:45
Conference/Events
ImmunoGen to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Downgrade
Aclaris Therapeutics rating change at SVB Leerink »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLS

Apellis

$23.45

-0.38 (-1.59%)

07:43
06/27/19
06/27
07:43
06/27/19
07:43
Hot Stocks
Apellis complete enrollment of Phase 3 APL-2 head-to-head study »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

TRIP

TripAdvisor

$44.04

-0.47 (-1.06%)

07:41
06/27/19
06/27
07:41
06/27/19
07:41
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$19.95

0.44 (2.26%)

07:40
06/27/19
06/27
07:40
06/27/19
07:40
Hot Stocks
Primoris announces industrial awards valued over $69M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$23.58

-0.24 (-1.01%)

07:39
06/27/19
06/27
07:39
06/27/19
07:39
Upgrade
KB Home rating change  »

KB Home upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPGN

OpGen

$0.40

-0.0123 (-2.95%)

07:39
06/27/19
06/27
07:39
06/27/19
07:39
Hot Stocks
OpGen says Acuitas panel shows potential to reduce total time to therapy »

OpGen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$28.94

0.035 (0.12%)

07:38
06/27/19
06/27
07:38
06/27/19
07:38
Hot Stocks
Conagra Brands down 7% to $26.83 after Q4 results miss estimates »

The company also lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.